Syros Pharma, Tyme up on stockholder approval of merger, reverse stock split plan

Syros Pharmaceuticals

15/09/2022 22:18

** Shares of drug developer Syros Pharmaceuticals  SYRS.O 
up 13.8% at 83 cents in aftermarket trade
    ** Shares rise after co announces stockholder approval of
merger with  biotechnology firm Tyme Technologies  TYME.O 
 urn:newsml:reuters.com:*:nBw1X0VCda
    ** TYME up 19.8% at 34 cents in aftermarket trade
    ** Merger is expected to close on Friday, Sept. 16       
    ** SYRS also announced a 1-for-10 reverse stock split of
common stock, effective Friday, after merger close
    ** Syros' common stock will begin trading on Nasdaq on a
split-adjusted basis when the market opens on Monday, Sept. 19,
2022
    ** Up to last close, SYRS fell 77.6% and TYME fell 52.3% YTD

 (Reporting by Nandhini Srinivasan in Bengaluru)
 ((Nandhini.srinivasan@thomsonreuters.com))